Detection of minimal residual disease in circulating cell-free DNA in acute myeloid leukemia
Hildegard I. D. Mack, Elisabeth Mack(Universitätsklinikum Gießen und Marburg), Andreas Neubauer(RWTH Aachen University), Madeleine C. Killer, Petra Ross(Universitätsklinikum Gießen und Marburg), Thorsten Stiewe(Philipps University of Marburg), Charlotte Sommer(Philipps University of Marburg), Andrea Nist(Philipps University of Marburg), Cornelia Brendel(Philipps University of Marburg)
Cited by 0
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573